Keywords: Concert Pharma, GlaxoSmithKline, HIV, Kidney disease, Spasticity, CTP-298, CTP-499, C-21191

Concert gets $4 million milestone in GlaxoSmithKline collaboration; progresses drug candidates

Article | 21 June 2011

Print This

US drug developer Concert Pharmaceuticals says that it has achieved a $4 million milestone in its strategic alliance with UK pharma ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in